Albany Molecular Research : AMRI Experts to Lead Discussion on Bringing a Medical Device to Market at MD&M Wes...	17.01.18
Albany Molecular Research : AMRI Names Michael Mulhern as Chief Executive Officer	04.01.18
Albany Molecular Research : AMRI’s SSCI Implements Next-Generation Analytical Instrumentation to Further Strengthen...	19.12.17
Albany Molecular Research : AMRI Doubles Bulk API Aseptic Manufacturing Capacity	30.11.17
Albany Molecular Research : AMRI Presents Expanded Capabilities at 2017 AAPS Annual Meeting	09.11.17

Manager	Titel	Alter	Seit
Philip W Macnabb CEO	Chief Executive Officer	-	01.05.23
Meera Khullar CMP	Compliance Officer	-	01.03.19
Prakash Pandian CTO	Chief Tech/Sci/R&D Officer	-	01.06.18

Aufsichtsräte	Titel	Alter	Seit
Dean Mihas BRD	Director/Board Member	57	-
Sean Cunningham BRD	Director/Board Member	48	-
William McMullan BRD	Director/Board Member	46	-

Unternehmensprofil

Sektor

	% 1. Jan.	Kap.
MODERNA, INC.	+40,80 %	53,67 Mrd.
LONZA GROUP AG	+35,79 %	38,86 Mrd.
IQVIA HOLDINGS INC.	-8,05 %	38,76 Mrd.
CELLTRION, INC.	-8,98 %	27,27 Mrd.
ICON PUBLIC LIMITED COMPANY	+10,69 %	25,91 Mrd.
ALNYLAM PHARMACEUTICALS, INC.	-16,21 %	20,29 Mrd.
UNITED THERAPEUTICS CORPORATION	+31,00 %	12,78 Mrd.
MEDPACE HOLDINGS, INC.	+28,51 %	12,18 Mrd.
BIO-TECHNE CORPORATION	-1,67 %	11,96 Mrd.